-
公开(公告)号:US20230193335A1
公开(公告)日:2023-06-22
申请号:US17759270
申请日:2021-01-22
Applicant: GLYCOM A/S
Inventor: Margit PEDERSEN , Manos PAPADAKIS , Katrine Bych KAMPMANN
CPC classification number: C12P19/04 , C12N9/1051 , C12Y204/01065 , C12Y204/01146 , C12N15/70 , C07K14/24
Abstract: The present inventive concept relates to a genetically modified cell enabled for the production of an oligosaccharide, preferably, an HMO, comprising a recombinant nucleic encoding a putative transporter protein of the MFS superfamily; and methods using said cell for the production of oligosaccharide(s), preferably an HMO.
-
公开(公告)号:US20230109937A1
公开(公告)日:2023-04-13
申请号:US17759276
申请日:2021-01-22
Applicant: GLYCOM A/S
Inventor: Margit PEDERSEN , Isotta D'ARRIGO , Katrine Bych KAMPMANN , Manos PAPADAKIS
Abstract: The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS), the protein expressed being Fred.
-
公开(公告)号:US20230227876A1
公开(公告)日:2023-07-20
申请号:US17759273
申请日:2021-01-22
Applicant: GLYCOM A/S
Inventor: Margit PEDERSEN , Katrine Bych KAMPMANN
Abstract: The present invention relates to the field of recombinant production of biological molecules in host cells. More particularly it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS).
-
公开(公告)号:US20230072639A1
公开(公告)日:2023-03-09
申请号:US17759267
申请日:2021-01-22
Applicant: GLYCOM A/S
Inventor: Margit PEDERSEN , Isotta D'ARRIGO , Katrine Bych KAMPMANN , Manos PAPADAKIS
Abstract: The present invention relates to the field of recombinant production of biological molecules in genetically modified cells. More particularly, it relates to a method for recombinant production of human milk oligosaccharides (HMO) using a genetically modified cell expressing a protein of the major facilitator superfamily (MFS), the protein expressed being Bad.
-
-
-